105 related articles for article (PubMed ID: 7734835)
1. Replication and persistence of coxsackieviruses B3 in human fibroblasts.
Tonew M; Hartmann M; Schmidtke M; Stelzner A
Zentralbl Bakteriol; 1995 Jan; 282(1):92-101. PubMed ID: 7734835
[TBL] [Abstract][Full Text] [Related]
2. Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1.
Schmidtke M; Selinka HC; Heim A; Jahn B; Tonew M; Kandolf R; Stelzner A; Zell R
Virology; 2000 Sep; 275(1):77-88. PubMed ID: 11017789
[TBL] [Abstract][Full Text] [Related]
3. Permissiveness of human embryonal fibroblasts for coxsackieviruses B3. Investigations on virus genetic markers in vitro and localization of virus receptor distribution by immunogold replica technique.
Tonew M; Wagner B; Wagner M; Schmidtke M; Stelzner A
Zentralbl Bakteriol; 1996 Jul; 284(2-3):443-56. PubMed ID: 8837403
[TBL] [Abstract][Full Text] [Related]
4. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses.
Chapman NM; Tu Z; Tracy S; Gauntt CJ
Arch Virol; 1994; 135(1-2):115-30. PubMed ID: 8198437
[TBL] [Abstract][Full Text] [Related]
5. [The suppressive effect of MiR-490 on coxsackievirus B3 replication].
Wang LL; Zhong ZH; Wang Q; Lu P; Li M; Xu HY
Bing Du Xue Bao; 2014 Nov; 30(6):619-23. PubMed ID: 25868275
[TBL] [Abstract][Full Text] [Related]
6. Chinese hamster ovary cells are non-permissive towards infection with coxsackievirus B3 despite functional virus-receptor interactions.
Kramer B; Huber M; Kern C; Klingel K; Kandolf R; Selinka HC
Virus Res; 1997 May; 48(2):149-56. PubMed ID: 9175253
[TBL] [Abstract][Full Text] [Related]
7. Transfection of prion protein gene suppresses coxsackievirus B3 replication in prion protein gene-deficient cells.
Nakamura Y; Sakudo A; Saeki K; Kaneko T; Matsumoto Y; Toniolo A; Itohara S; Onodera T
J Gen Virol; 2003 Dec; 84(Pt 12):3495-3502. PubMed ID: 14645931
[TBL] [Abstract][Full Text] [Related]
8. Characterization of coxsackievirus B3 replication in human umbilical vein endothelial cells.
Kühnl A; Rien C; Spengler K; Kryeziu N; Sauerbrei A; Heller R; Henke A
Med Microbiol Immunol; 2014 Aug; 203(4):217-29. PubMed ID: 24615265
[TBL] [Abstract][Full Text] [Related]
9. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.
Kim KS; Tracy S; Tapprich W; Bailey J; Lee CK; Kim K; Barry WH; Chapman NM
J Virol; 2005 Jun; 79(11):7024-41. PubMed ID: 15890942
[TBL] [Abstract][Full Text] [Related]
10. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions.
Sato S; Tsutsumi R; Burke A; Carlson G; Porro V; Seko Y; Okumura K; Kawana R; Virmani R
J Gen Virol; 1994 Nov; 75 ( Pt 11)():2911-24. PubMed ID: 7964602
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro.
Feuer R; Mena I; Pagarigan R; Slifka MK; Whitton JL
J Virol; 2002 May; 76(9):4430-40. PubMed ID: 11932410
[TBL] [Abstract][Full Text] [Related]
12. Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment.
Carson SD; Chapman NM; Hafenstein S; Tracy S
J Virol; 2011 Apr; 85(7):3306-14. PubMed ID: 21270163
[TBL] [Abstract][Full Text] [Related]
13. Coxsackievirus B3 induces the formation of autophagosomes in cardiac fibroblasts both in vitro and in vivo.
Zhai X; Qin Y; Chen Y; Lin L; Wang T; Zhong X; Wu X; Chen S; Li J; Wang Y; Zhang F; Zhao W; Zhong Z
Exp Cell Res; 2016 Dec; 349(2):255-263. PubMed ID: 27793649
[TBL] [Abstract][Full Text] [Related]
14. Coxsackievirus B3-induced calpain activation facilitates the progeny virus replication via a likely mechanism related with both autophagy enhancement and apoptosis inhibition in the early phase of infection: an in vitro study in H9c2 cells.
Li M; Wang X; Yu Y; Yu Y; Xie Y; Zou Y; Ge J; Peng T; Chen R
Virus Res; 2014 Jan; 179():177-86. PubMed ID: 24177271
[TBL] [Abstract][Full Text] [Related]
15. Coxsackievirus group B replication in cultured fetal baboon aortic smooth muscle cells.
Godeny EK; Sprague EA; Schwartz CJ; Gauntt CJ
J Med Virol; 1986 Oct; 20(2):135-49. PubMed ID: 3021897
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent.
Esfandiarei M; Luo H; Yanagawa B; Suarez A; Dabiri D; Zhang J; McManus BM
J Virol; 2004 Apr; 78(8):4289-98. PubMed ID: 15047842
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of glycogen synthase kinase 3beta suppresses coxsackievirus-induced cytopathic effect and apoptosis via stabilization of beta-catenin.
Yuan J; Zhang J; Wong BW; Si X; Wong J; Yang D; Luo H
Cell Death Differ; 2005 Aug; 12(8):1097-106. PubMed ID: 15905881
[TBL] [Abstract][Full Text] [Related]
18. Heparan Sulfate Binding Coxsackievirus B3 Strain PD: A Novel Avirulent Oncolytic Agent Against Human Colorectal Carcinoma.
Hazini A; Pryshliak M; Brückner V; Klingel K; Sauter M; Pinkert S; Kurreck J; Fechner H
Hum Gene Ther; 2018 Nov; 29(11):1301-1314. PubMed ID: 29739251
[TBL] [Abstract][Full Text] [Related]
19. Coxsackievirus B3 replication and persistence in intestinal cells from mice infected orally and in the human CaCo-2 cell line.
Harrath R; Bourlet T; Delézay O; Douche-Aourik F; Omar S; Aouni M; Pozzetto B
J Med Virol; 2004 Oct; 74(2):283-90. PubMed ID: 15332278
[TBL] [Abstract][Full Text] [Related]
20. Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway.
Si X; McManus BM; Zhang J; Yuan J; Cheung C; Esfandiarei M; Suarez A; Morgan A; Luo H
J Virol; 2005 Jul; 79(13):8014-23. PubMed ID: 15956547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
